Andreas Schlicker

5PUBLICATIONS
118CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 10, 2026
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

|Jun 14, 2025
Phase Ib Basket Expansion Trial and Alternative-Schedule Dose-Escalation Study of ATR Inhibitor Elimusertib in Advanced Solid Tumors with DNA Damage Response Defects.

Timothy A Yap, David S P Tan, Anastasios Stathis

|Jan 08, 2025
Darolutamide in Combination with Radium-223 Exhibits Synergistic Antitumor Efficacy in LNCaP Prostate Cancer Models.

Urs B Hagemann, Christoph A Schatz, Mari I Suominen

|May 26, 2021
Darolutamide Potentiates the Antitumor Efficacy of a PSMA-targeted Thorium-227 Conjugate by a Dual Mode of Action in Prostate Cancer Models.

Stefanie Hammer, Andreas Schlicker, Sabine Zitzmann-Kolbe

|Apr 10, 2020
Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasis.

Andreas Schlicker, Architha Ellappalayam, Ines J Beumer

Pageof 1

Frequent Collaborators

2 joint publications

Bernard Haendler

1 joint publications

Fotios Loupakis

1 joint publications

Filippo Pietrantonio

1 joint publications

Giovanni Fucà